Blog

Preparation for ketamine-assisted psychotherapy (KAP) involves several key components aimed at ensuring the safety and efficacy of the treatment, as well as preparing the patient mentally and emotionally for the experience. Keep reading.

In recent years, ketamine-assisted psychotherapy (KAP) has emerged as a promising treatment for various mental health conditions, offering new hope to individuals who have not found relief through conventional therapies. Learn more.

This episode of the ThinkNeuro Podcast join us as we delve into this paradigm shift, uncovering how PNI is blazing a trail in the realm of psychedelic-assisted therapies.

Ketamine-assisted psychotherapy (KAP) is emerging as a significant therapeutic approach for various mental health conditions. However, the efficacy of KAP is greatly enhanced when coupled with a crucial component: integration. Learn how Pacific Neuroscience Institute® (PNI®)'s Treatment & Research in Psychedelics (TRIP) Center uses integration to optimize patient outcomes.

Explore the transformative benefits of ketamine therapy in treating treatment-resistant depression, anxiety disorders, PTSD, chronic pain, and addiction. Learn how Pacific Neuroscience Institute's expert team harnesses the potential of ketamine to offer hope and relief.

We are excited to announce the expansion of our psychedelics program into a new center of excellence: The Pacific Treatment & Research in Psychedelics (TRIP). As a leader in psychedelic research, Pacific Neuroscience Institute (PNI) continues to pioneer innovative mental health solutions.

Pacific Neuroscience Institute® experts discuss the signs and symptoms of anxiety. Discover the latest treatment and innovations at PNI's Pacific Treatment & Research In Psychedelics (TRIP) program.

Cancer patients may find relief from mental anguish with ketamine-assisted therapy available at Saint John’s Health Center and Pacific Neuroscience Institute ® (PNI).

At Pacific Neuroscience Institute® (PNI) we achieved many milestones in 2022 and continue to make positive impacts in neuroscience clinical care, research, and education.

After a decades-long pause, psychedelics are once again being investigated for their transdiagnostic treatment potential. Discover the future of psychedelics in neurosurgery and neuro-oncology with experts from Pacific Neuroscience Institute ® (PNI).